Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
Abstract
Plasma viremia reoccurs in most HIV-infected individuals once antiretroviral therapy is interrupted, and interindividual differences in the kinetics of viral rebound have been associated with virological and immunological factors. Antibody features, including Fc functionality and Fc glycosylation, have been identified as sensitive surrogates for disease activity in multiple diseases.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 27, 2021
- Source ID
- 10.1128/mbio.00170-21
Entities
People
- Anchalee Avihingsanon
- Bernard Hirschel
- Boris Julg
- Carolin Loos
- Dansu Yuan
- Douglas A. Lauffenburger
- Evan Rossignol
- Galit Alter
- Jesse M. Fajnzylber
- Jintanat Ananworanich
- Jonathan Z Li
- Sasiwimol Ubolyam
- Thidarat Jupimai
- Yannic C. Bartsch
Organizations
- Chulalongkorn University
- Geneva University Hospitals
- Harvard Medical School
- Harvard University
- Massachusetts Institute of Technology
- Thai Red Cross Society
- United States Department of Defense
- University of Amsterdam